This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2016 Jul;17(7):e270.

doi: 10.1016/S1470-2045(16)30232-7. Epub 2016 Jun 28.

Correction to Lancet Oncol 2016; 17: 995, 1002

No authors listed

PMID: 27733293
DOI: 10.1016/S1470-2045(16)30232-7

Published Erratum

Correction to Lancet Oncol 2016; 17: 995, 1002

No authors listed. Lancet Oncol. 2016 Jul.

. 2016 Jul;17(7):e270.

doi: 10.1016/S1470-2045(16)30232-7. Epub 2016 Jun 28.

PMID: 27733293
DOI: 10.1016/S1470-2045(16)30232-7

No abstract available

PubMed Disclaimer

Erratum for

Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial.
Cella D, Grünwald V, Nathan P, Doan J, Dastani H, Taylor F, Bennett B, DeRosa M, Berry S, Broglio K, Berghorn E, Motzer RJ. Cella D, et al. Lancet Oncol. 2016 Jul;17(7):994-1003. doi: 10.1016/S1470-2045(16)30125-5. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283863 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations